Current care in multiple sclerosis (MS) primarily relies on infrequently obtained data such as magnetic resonance imaging, clinical laboratory tests or clinical history, resulting in subtle changes ...

An eight minute scan could replace painful spinal taps in diagnosing multiple sclerosis, a study has found.The neurological ...

Discover the multiple sclerosis (MS) patterns that standard brain scans frequently overlook and why these missed indicators ...

Foralumab is the only fully human anti-CD3 monoclonal antibody in clinical development for intranasal delivery. By modulating ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation ...

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients. All patients experienced stabilization of Expanded Disability ...

Researchers have identified biomarkers that, in conjunction with PET imaging, enable doctors to reliably distinguish between primary 4-repeat tauopathies and Alzheimer's disease. In some patients with ...

Widespread use of MRI (magnetic resonance imaging) has revolutionized the ability to diagnose multiple sclerosis. Disease-related changes in the brain or spinal cord are detected by MRI in more ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS). The research combined PET imaging data from 114 ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis ... The research combined PET imaging data from 114 Finnish ...

Researchers have identified a new biomarker in multiple sclerosis (MS): the thickness of the inflammatory rim surrounding brain lesions predicts how quickly and severely the disease progresses. By ...